Core Viewpoint - Spring Medical's stock closed at 23.99 yuan, up 6.39%, with a rolling PE ratio of 71.97, marking a new low in 379 days, and a total market capitalization of 9.202 billion yuan [1] Company Summary - Spring Medical specializes in the research, production, and sales of implantable orthopedic medical devices, including spinal, trauma, joint, sports medicine, bone repair materials, surgical instruments, PRP preparation kits, and negative pressure wound drainage kits [1] - The company was recognized as a champion enterprise in the artificial joint prosthesis manufacturing industry by the Ministry of Industry and Information Technology in 2024 [1] - For Q1 2025, Spring Medical reported revenue of 230 million yuan, a year-on-year increase of 3.60%, and a net profit of 58.0711 million yuan, up 5.20%, with a gross profit margin of 66.69% [1] Industry Summary - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Spring Medical at the 92nd position in the industry ranking [1] - The total market capitalization of the industry averages 11.897 billion yuan, with the median at 5.767 billion yuan [2]
春立医疗收盘上涨6.39%,滚动市盈率71.97倍,总市值92.02亿元